Skip to content
MarketScale
‹ Back to IndustriesEngineering & Construction

On-site hydrogen: what’s the big deal?

For years, one of the issues with hydrogen has been that it is manufactured at one facility – sometimes as a byproduct – then taken elsewhere. But what if the hydrogen could be made on-site? It would cut down on costs and make the process simpler. On this episode of Purple Is the New…

This story was produced through MarketScale. See how Engineering & Construction teams put it to work with Partner & Channel Enablement.

Share

For years, one of the issues with hydrogen has been that it is manufactured at one facility – sometimes as a byproduct – then taken elsewhere.

But what if the hydrogen could be made on-site? It would cut down on costs and make the process simpler. On this episode of Purple Is the New Green, David Wolff, Nel Hydrogen’s Region Manager for the Eastern U.S. and Canada, said that scenario already is a reality.

“We have 18 Nel hydrogen generators deployed that were sold to a Ford engine assembly plant in Canada. This is at a massive Ford engine building plant,” he said. “These 18 hydrogen generators are serving to supply hydrogen for plasma spray of a cast iron-like lining on the inner cylinder bore of aluminum engine blocks.”

Those engines go in the Ford EcoBoost engine used in the F-150, North America’s best-selling vehicle family. “We’re very proud of that use of our hydrogen generators,” Wolff said.

It’s a great example of creating the hydrogen on-site when needed rather than having to deal with the drawbacks that can come with transportation. Yet, Wolff said too few people understand that having on-site hydrogen is an option.

“One of the challenges for … Nel over the years in the industrial world has been making people aware that on-site hydrogen was an alternative,” he said, comparing it to people getting milk delivered by a milkman. “You had to make people aware there were other ways to get your milk.

“In this case, it’s even better, because you can get your hydrogen and you can make it yourself.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Engineering & Construction: are you visible to AI?

Before they reach out, Engineering & Construction buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Engineering & Construction expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Engineering & Construction expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Engineering & Construction Insights

What Challenges Are Manufacturers Facing Under Annex 1?

What Challenges Are Manufacturers Facing Under Annex 1?

Manufacturers are facing significant challenges under Annex 1, which regulates sterile production processes. Compliance with these regulations is critical for maintaining product safety and quality. Identifying potential risks and implementing effective control measures are key aspects for manufacturers to address.

  • 01Annex 1 presents challenges in maintaining sterile production processes for manufacturers.
  • 02Compliance with Annex 1 regulations is crucial for product safety and quality.
  • 03Manufacturers must identify risks and implement effective control measures.

Aug 3, 2026

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

Pharmaceutical manufacturers face significant challenges such as ensuring quality control, navigating regulatory requirements, and managing supply chain disruptions. These issues are intensified by the need for innovation and rapid response to market demands. Companies must balance these factors to remain competitive in the industry.

  • 01Quality control is a major challenge for pharmaceutical manufacturers.
  • 02Regulatory compliance is essential but can be complex and time-consuming.
  • 03Supply chain disruptions require strategic management and contingency planning.

Aug 3, 2026

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

Industrial real estate construction in the U.S. reached over 305 million square feet in the second quarter of 2026, an 18% increase from the previous year. The surge is largely driven by demand from data-center equipment suppliers. This trend highlights the growing influence of data centers on industrial real estate recovery.

  • 01U.S. industrial real estate construction increased by 18% year-over-year in Q2 2026.
  • 02Demand for new constructions is primarily driven by data-center equipment suppliers.
  • 03Over 305 million square feet of industrial space is under development.

Aug 1, 2026

Explore More Engineering & Construction Insights

Read more expert perspectives from across Engineering & Construction.

Browse Engineering & Construction Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Engineering & Construction and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512